Bath & Body Works (NYSE:BBWI) Given New $52.00 Price Target at Deutsche Bank Aktiengesellschaft

Bath & Body Works (NYSE:BBWI) had its price target hoisted by Deutsche Bank Aktiengesellschaft from $51.00 to $52.00 in a report released on Tuesday,Benzinga reports. The firm currently has a buy rating on the stock.

Other research analysts have also recently issued research reports about the stock. Raymond James lowered their price target on shares of Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating on the stock in a research report on Thursday, August 29th. BMO Capital Markets reissued an “outperform” rating and issued a $50.00 price target (down previously from $52.00) on shares of Bath & Body Works in a research note on Thursday, August 29th. JPMorgan Chase & Co. lifted their price target on shares of Bath & Body Works from $35.00 to $39.00 and gave the company a “neutral” rating in a research report on Tuesday. Robert W. Baird decreased their price objective on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a report on Thursday, August 29th. Finally, Evercore ISI cut their target price on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a research note on Wednesday, August 28th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $41.88.

Bath & Body Works Price Performance

BBWI stock opened at $35.23 on Tuesday. Bath & Body Works has a 1 year low of $26.20 and a 1 year high of $52.99. The firm has a market capitalization of $7.72 billion, a PE ratio of 8.53, a price-to-earnings-growth ratio of 0.98 and a beta of 1.79. The business has a 50 day simple moving average of $30.69 and a 200-day simple moving average of $35.74.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. On average, equities research analysts expect that Bath & Body Works will post 3.18 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 22nd will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.27%. The ex-dividend date of this dividend is Friday, November 22nd. Bath & Body Works’s payout ratio is 19.37%.

Insider Buying and Selling

In related news, CEO Gina Boswell acquired 6,000 shares of the firm’s stock in a transaction dated Wednesday, October 9th. The stock was acquired at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the purchase, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This represents a 2.53 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.27% of the stock is owned by insiders.

Hedge Funds Weigh In On Bath & Body Works

Several large investors have recently bought and sold shares of the business. California State Teachers Retirement System lifted its position in shares of Bath & Body Works by 1.4% during the 1st quarter. California State Teachers Retirement System now owns 345,749 shares of the company’s stock worth $17,294,000 after buying an additional 4,695 shares during the last quarter. Tidal Investments LLC raised its stake in Bath & Body Works by 223.9% during the 1st quarter. Tidal Investments LLC now owns 19,398 shares of the company’s stock worth $970,000 after acquiring an additional 13,410 shares in the last quarter. Atria Investments Inc purchased a new stake in Bath & Body Works in the first quarter valued at $1,058,000. Northwest Bank & Trust Co boosted its stake in Bath & Body Works by 2.5% in the first quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock valued at $655,000 after acquiring an additional 315 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale grew its holdings in shares of Bath & Body Works by 1.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock worth $1,560,000 after purchasing an additional 322 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.